Citing concerns about sterility, Lowlite Investments (d/b/a Olympia Pharmacy) in Orlando, FL has recently recalled “all sterile drug products compounded by the pharmacy that have not reached the expiration date listed on the product,” according to a recent FDA report.

With respect to the present concern over the safety of products sold as sterile by Olympia Pharmacy, The FDA stated on May 29th, “In the event a sterile product is compromised patients are at risk for serious and possible life threatening infections.”

Though no reports of injury resulting from contaminated Olympia Pharmacy products have been made to the FDA to-date, if you bought products manufactured by Olympia Pharmacy that have a “use by date of 09/25/2013 or earlier.”  The FDA also states that “Olympia Pharmacy will be notifying customers by phone, fax, or mail to return the products to the pharmacy.”

Thankfully, according to a report by Megan Brooks at, Olympia Pharmacy has stated this recall was “conducted as a ‘precautionary measure’.”

According to the FDA, “Healthcare professionals and patients are encouraged to report adverse events or side effects related to the use of these products to the FDA’s MedWatch Safety Information and Adverse Event Reporting Program

  • Complete and submit the report Online:
  • Download form or call 1-800-332-1088 to request a reporting form, then complete and return to the address on the pre-addressed form, or submit by fax to 1-800-FDA-0178

[05/30/2013 – Press Release – Olympia Pharmacy]

[05/30/2013 – Recalled Product List – Olympia Pharmacy]”

This recall, however, is simply only one of many compounding pharmacies recently to recall products with questionable sterility.  Here is table explaining recent similar recalls, provided by the FDA.

Please click the image below to enlarge